Staffordshire Bull Terrier NCL and the ARSG Gene: What the Research Shows About This Late-Onset Neurological Disease

Bottom line: Neuronal ceroid lipofuscinosis (NCL) of the NCL-4A type is linked to a variant in the ARSG gene (p.R99H), inherited in an autosomal-recessive pattern and beginning late in life (roughly 3–6 years). The variant was first characterised in the American Staffordshire Terrier, and the same NCL-4A test is offered for the closely related Staffordshire Bull Terrier. A DNA test reports a dog’s genetic and breeding status (clear / carrier / affected) but is not a clinical diagnosis. NCL is currently incurable; the test is for information and breeding planning. If your Staffie shows neurological signs, your vet and a veterinary neurologist are the right people to see.

What NCL is and how the ARSG mechanism works

SamMy Staffie’s pedigree mentions “NCL-4A”. What actually goes wrong inside the body?

Elena MarshNCL is an inherited lysosomal storage disease. Abitbol et al. (2010) identified an ARSG variant that cuts arylsulfatase G activity by about 75%, and the same variant is tested in Staffordshire Bull Terriers today.

Neuronal ceroid lipofuscinosis belongs to a group of inherited, progressive neurodegenerative storage disorders in which the cell’s normal lysosomal breakdown process fails. As a result, autofluorescent storage material made of ceroid and lipofuscin gradually accumulates inside nerve cells. A comprehensive veterinary review describes this mechanism and maps the breed-specific gene variants of canine NCL (Katz et al. 2017). Because neurons no longer divide, they cannot “dilute” these deposits — the material builds up and is associated with progressive loss of nerve cells.

The NCL-4A form was traced to a missense variant in exon 2 of the ARSG gene (arylsulfatase G), producing an amino-acid change, p.R99H, close to the catalytic domain. Working with American Staffordshire Terrier pedigrees from the United States and France, Abitbol et al. (2010) showed that this variant reduces arylsulfatase G activity by roughly 75% and causes a late-onset, autosomal-recessive NCL, mapping the disease locus to canine chromosome 9. The Staffordshire Bull Terrier shares the same Staffordshire and bull-and-terrier ancestry, which is why reference and direct-to-consumer labs offer this identical NCL-4A test for the Staffie — it is a related-breed test, not a separate Staffie-specific discovery.

Onset and signs in the Staffordshire Bull Terrier

SamMy Staffie is four and sometimes seems a bit wobbly. Could that already be NCL?

Elena MarshAn early clue can indeed be mild loss of balance — but the NCL-4A form typically begins only at 3–6 years, according to Abitbol et al. (2010).

Unlike the early-onset NCL forms seen in some other breeds, NCL-4A is a late-onset disease. Onset is usually reported at around 3 to 6 years of age — a point at which a dog may already have been used for breeding. The first signs are often subtle: a mild impairment of balance and cerebellar ataxia (an unsteady, uncoordinated gait). Because Staffordshire Bull Terriers are such lively, athletic family dogs, an owner may first notice a slight hesitation before jumping onto the sofa or a small stumble on the stairs.

As the condition advances, progressive signs are described: tremor, abnormal eye movements, difficulty jumping and balancing, and a worsening motor decline that can eventually include seizures (Katz et al. 2017). The disease is described as relentlessly progressive, and affected dogs are commonly euthanised roughly two to four years after signs begin. It is important to stress that these are research observations, not a guaranteed forecast for any individual dog — the course must be assessed by a vet.

Inheritance and carrier testing

SamMy bitch is listed as a “carrier” but she’s perfectly healthy. How can that be?

Elena MarshThat’s normal for recessive traits: carriers hold just one copy and stay clinically healthy — Abitbol et al. (2010) confirmed this recessive segregation across US and French pedigrees.

NCL-4A, like almost all canine NCL forms, is inherited in an autosomal-recessive pattern. A dog develops the disease only if it inherits two copies of the variant (homozygous affected). Heterozygous carriers hold a single copy, stay clinically healthy, and can pass the variant silently to their offspring. Abitbol et al. (2010) confirmed this recessive segregation in American Staffordshire Terrier pedigrees from both the United States and France, and the same recessive logic applies to the Staffordshire Bull Terrier because it is the identical variant being tested.

This is exactly why carrier testing before breeding is the only reliable way to avoid affected puppies. A carrier × carrier mating can, on average, produce affected pups, whereas mating a clear dog to a carrier (clear × carrier) produces no affected puppies while preserving the breed’s genetic diversity. Registries list the test under the name NCL-4A / ARSG; the OFA registry records breed-specific NCL results and feeds into the AKC/OFA CHIC health database.

How to test in the UK and US

SamWhere can I actually get the ARSG test done here in the UK or US?

Elena MarshSeveral reference labs offer the NCL-4A Staffordshire Bull Terrier test directly — for example Paw Print Genetics/Orivet, Embark and the Cambridge CAGT laboratory.

In the UK and US, several laboratories run the ARSG / NCL-4A test for the Staffordshire Bull Terrier. In the US these include Paw Print Genetics/Orivet (listed as NCL4A for the Staffordshire Bull Terrier), Embark (which screens for NCL4A within its health panel), and the university laboratory UC Davis Veterinary Genetics Laboratory. In the UK, owners often use the Cambridge CAGT (Centre for Animal Genetic Testing). In practice, sampling is usually a buccal (cheek) swab that your vet takes or that you collect at home and post to the lab. A single breed-specific test is typically in the region of about $50–$70 or £40–£60 — treat this as approximate and check the current price with the lab, as bundled health panels are priced differently.

For breeders, the registry context matters. In the UK, pedigree breeding is organised through The Kennel Club, whose Assured Breeder Scheme encourages relevant health testing and recording of results. In the US, the AKC and the OFA/CHIC framework play the equivalent role, letting breeders publish DNA results transparently. Recording a clear, carrier or affected status on a public registry helps other breeders plan clear × carrier matings and gradually reduce carrier frequency without shrinking the gene pool.

One point Staffie owners often ask about: unlike the American Pit Bull Terrier, the Staffordshire Bull Terrier is not a banned breed under the UK’s Dangerous Dogs Act 1991 — it is in fact one of Britain’s most popular and well-loved family breeds. That is worth stating responsibly, but it does not change the genetic advice: any Staffie used for breeding should still be tested for NCL-4A. If a dog shows neurological signs, the path runs from your regular vet to a veterinary neurologist.

What a DNA test shows — and what it doesn’t

SamIf the test says “affected”, does that mean my dog is already officially ill?

Elena MarshNo. The test reports the genotype, not a clinical diagnosis — that comes from a veterinary neurologist; and NCL has no treatment so far (Katz et al. 2017).

The ARSG DNA test assigns a dog to one of three genotypes: clear (no copy), carrier (heterozygous, one copy) or affected (homozygous, two copies). This is above all valuable for breeding planning: mating a clear dog with a carrier (clear × carrier) produces no affected puppies and keeps the breed’s genetic diversity intact. The test therefore delivers a genetic risk and breeding status.

What it does not do: it is not a clinical diagnosis. Whether and when an “affected” dog actually develops neurological signs, and how those signs progress, is determined by examination through a veterinary neurologist, not by the lab. NCL is not curable with current knowledge; the test serves information and breeding decisions, not treatment (Katz et al. 2017). A “carrier” result explicitly does not mean the dog is ill — it is information for responsible mating.

Frequently asked questions

Q. My Staffordshire Bull Terrier tested “affected” — will it definitely develop NCL?
The test detects the genotype, not a certain forecast for the individual. NCL-4A is associated with the ARSG variant (p.R99H) and, in research, typically begins at 3–6 years (Abitbol et al. 2010). Whether and how signs appear should be assessed by a veterinary neurologist — a DNA test does not replace that examination.

Q. The variant was found in the American Staffordshire Terrier — is the test valid for my Staffordshire Bull Terrier?
The disease-causing variant was first characterised in the American Staffordshire Terrier (Abitbol et al. 2010), and labs offer the identical NCL-4A test for the closely related Staffordshire Bull Terrier because the two breeds share Staffordshire and bull-and-terrier ancestry. It is the same variant, tested in a related breed — not a separate Staffie-specific discovery.

Q. Why bother testing if carriers are healthy?
Because NCL is autosomal-recessive: two healthy carriers can together produce affected puppies. Carrier testing before breeding lets you mate clear × carrier, which avoids affected offspring while preserving diversity. You can record results with The Kennel Club (UK) or OFA/CHIC (US) so other breeders can plan safe matings.

Q. How is the sample taken and roughly what does it cost?
Sampling is usually a simple buccal (cheek) swab, collected by your vet or at home and posted to the lab. A single breed-specific test is typically around $50–$70 or £40–£60, but this is approximate — confirm the current price and turnaround directly with the laboratory.

References

• Abitbol M et al. (2010) A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis. Proceedings of the National Academy of Sciences USA 107(33):14775–14780. https://pubmed.ncbi.nlm.nih.gov/20679209/
• Katz ML et al. (2017) Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions. Neurobiology of Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC5675811/
• Orthopedic Foundation for Animals (OFA) — Neuronal Ceroid Lipofuscinosis, breed-specific DNA test registry (NCL-4A / ARSG). https://ofa.org/neuronal-ceroid-lipofuscinosis/
• Paw Print Genetics / Orivet — Neuronal Ceroid Lipofuscinosis 4A (NCL4A), Staffordshire Bull Terrier. https://www.pawprintgenetics.com/
• The Kennel Club (UK) — Health testing and screening schemes / Assured Breeder Scheme. https://www.thekennelclub.org.uk/breeding/health-testing-and-screening-schemes/

About the author

Elena Marsh

Editor & writer (not a veterinarian)

A writer with a molecular-biology background and a lifelong dog and cat owner. Not a veterinarian — she translates peer-reviewed genetics research and primary data into plain language, always as information rather than diagnosis.